Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511576
Status:
TERMINATED
Last Update Posted:
2015-01-08
First Post:
2007-08-03
Brief Title:
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel Taxotere for Subjects With Advanced Cancer Tumors
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Organization Data
Organization:
Mirati Therapeutics Inc
Class:
INDUSTRY
Study ID:
103 PH US 2007 CL001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mirati Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gregory Reid Executive Director Clinical Development
Old Organization:
MethylGene Inc